Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||
| Cash income from operating activities | ||||||||
| Cash paid | -33.79%-2.22M | 38.82%-1.66M | -2.43%-2.71M | -148.35%-2.65M | -14.48%-1.07M | 8.71%-932.03K | 5.96%-1.02M | -1.09M |
| Payments to suppliers for goods and services | -33.79%-2.22M | 38.82%-1.66M | -2.43%-2.71M | -148.35%-2.65M | -14.48%-1.07M | 8.71%-932.03K | -79.82%-1.02M | ---567.76K |
| Other cash payments from operating activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---517.91K |
| Direct interest received | -13.44%85.44K | 131.78%98.7K | 12,687.99%42.58K | 211.21%333 | -98.21%107 | -87.04%5.97K | 5.93%46.08K | --43.5K |
| Operating cash flow | -36.77%-2.14M | 41.54%-1.56M | -0.84%-2.67M | -148.34%-2.65M | -15.21%-1.07M | 5.01%-926.06K | 6.46%-974.88K | ---1.04M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | -318.48%-10.8M | 64.09%-2.58M | -175.64%-7.19M | -674.76%-2.61M | 132.44%453.53K | -88.60%-1.4M | -420.41%-741.32K | -142.45K |
| Net PPE purchase and sale | -265.17%-10.18M | 35.78%-2.79M | -73.55%-4.34M | -1,984.32%-2.5M | 83.55%-120K | -2,332.28%-729.68K | 78.94%-30K | ---142.45K |
| Net business purchase and sale | ---1.25M | ---- | ---- | --8.58K | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | 318.70%554.4K | 104.67%132.41K | -4,198.58%-2.83M | -87.94%69.15K | 185.80%573.53K | 6.03%-668.46K | ---711.32K | ---- |
| Net other investing changes | 2.92%77.19K | 850.00%75K | 94.54%-10K | ---183.24K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | -318.48%-10.8M | 64.09%-2.58M | -175.64%-7.19M | -674.76%-2.61M | 132.44%453.53K | -88.60%-1.4M | -420.41%-741.32K | ---142.45K |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 52.70%11.14M | -28.04%7.29M | 213.58%10.14M | 9.62%3.23M | 2.95M | 6.09M | ||
| Net common stock issuance | 52.70%11.14M | -28.04%7.29M | 213.58%10.14M | 9.62%3.23M | --2.95M | ---- | ---- | --6.09M |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | 52.70%11.14M | -28.04%7.29M | 213.58%10.14M | 9.62%3.23M | --2.95M | ---- | ---- | --6.09M |
| Net cash flow | ||||||||
| Beginning cash position | 214.38%4.62M | 23.40%1.47M | -62.96%1.19M | 265.55%3.21M | -72.61%879.41K | -34.83%3.21M | 25,747.02%4.93M | --19.06K |
| Current changes in cash | -157.04%-1.8M | 1,031.13%3.15M | 113.76%278.56K | -186.67%-2.02M | 200.47%2.34M | -35.43%-2.32M | -134.97%-1.72M | --4.91M |
| Effect of exchange rate changes | 377.59%3.64K | ---1.31K | ---- | ---- | ---- | ---- | ---- | ---- |
| End cash Position | -38.84%2.83M | 214.38%4.62M | 23.40%1.47M | -62.96%1.19M | 262.60%3.21M | -72.39%886.56K | -34.83%3.21M | --4.93M |
| Free cash from | -184.58%-12.88M | 35.93%-4.52M | -37.12%-7.06M | -333.96%-5.15M | 28.32%-1.19M | -64.77%-1.66M | 15.17%-1M | ---1.18M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |